NR1H4 and obesity due to melanocortin 4 receptor deficiency: Numerous studies in recent years have revealed the crucial importance of impaired FXR functions in obesity [74–77], CVD [78, 79], non-alcoholic fatty liver disease [80], metabolic syndrome [81], type 2 diabetes mellitus [82], and also other diseases.